These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 25041501
21. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance. McCann UD, Szabo Z, Vranesic M, Palermo M, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA. Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256 [Abstract] [Full Text] [Related]
22. Neuroimaging research in human MDMA users: a review. Cowan RL. Psychopharmacology (Berl); 2007 Jan; 189(4):539-56. PubMed ID: 16847678 [Abstract] [Full Text] [Related]
23. Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender. de Win MM, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W. Psychopharmacology (Berl); 2004 May; 173(3-4):376-82. PubMed ID: 14726997 [Abstract] [Full Text] [Related]
24. Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans. McCann UD, Ridenour A, Shaham Y, Ricaurte GA. Neuropsychopharmacology; 1994 Apr; 10(2):129-38. PubMed ID: 7517677 [Abstract] [Full Text] [Related]
25. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Reneman L, Booij J, Schmand B, van den Brink W, Gunning B. Psychopharmacology (Berl); 2000 Feb; 148(3):322-4. PubMed ID: 10755746 [Abstract] [Full Text] [Related]
26. Acute effects of 3,4-methylenedioxymethamphetamine on brain serotonin synthesis in the dog studied by positron emission tomography. Nishisawa S, Mzengeza S, Diksic M. Neurochem Int; 1999 Jan; 34(1):33-40. PubMed ID: 10100194 [Abstract] [Full Text] [Related]
27. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O. J Psychopharmacol; 2006 May; 20(3):389-99. PubMed ID: 16574713 [Abstract] [Full Text] [Related]
28. Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907. Urban NB, Girgis RR, Talbot PS, Kegeles LS, Xu X, Frankle WG, Hart CL, Slifstein M, Abi-Dargham A, Laruelle M. Neuropsychopharmacology; 2012 May; 37(6):1465-73. PubMed ID: 22353758 [Abstract] [Full Text] [Related]
29. Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users. Roberts CA, Jones A, Montgomery C. Neurosci Biobehav Rev; 2016 Apr; 63():158-67. PubMed ID: 26855234 [Abstract] [Full Text] [Related]
30. Serotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy use. Laursen HR, Henningsson S, Macoveanu J, Jernigan TL, Siebner HR, Holst KK, Skimminge A, Knudsen GM, Ramsoy TZ, Erritzoe D. J Psychopharmacol; 2016 Dec; 30(12):1296-1304. PubMed ID: 27599522 [Abstract] [Full Text] [Related]
31. Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users. Bosch OG, Wagner M, Jessen F, Kühn KU, Joe A, Seifritz E, Maier W, Biersack HJ, Quednow BB. PLoS One; 2013 Dec; 8(4):e61234. PubMed ID: 23585882 [Abstract] [Full Text] [Related]
33. Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations. Price LH, Ricaurte GA, Krystal JH, Heninger GR. Arch Gen Psychiatry; 1989 Jan; 46(1):20-2. PubMed ID: 2562914 [Abstract] [Full Text] [Related]
34. Gender differences in alpha-[(11)C]MTrp brain trapping, an index of serotonin synthesis, in medication-free individuals with major depressive disorder: a positron emission tomography study. Frey BN, Skelin I, Sakai Y, Nishikawa M, Diksic M. Psychiatry Res; 2010 Aug 30; 183(2):157-66. PubMed ID: 20630715 [Abstract] [Full Text] [Related]
35. Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users. Croft RJ, Klugman A, Baldeweg T, Gruzelier JH. Am J Psychiatry; 2001 Oct 30; 158(10):1687-92. PubMed ID: 11579003 [Abstract] [Full Text] [Related]
36. Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users. Roberts CA, Wetherell MA, Fisk JE, Montgomery C. Psychol Med; 2015 Jan 30; 45(2):395-406. PubMed ID: 25066866 [Abstract] [Full Text] [Related]
37. Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'). Ricaurte GA, McCann UD, Szabo Z, Scheffel U. Toxicol Lett; 2000 Mar 15; 112-113():143-6. PubMed ID: 10720723 [Abstract] [Full Text] [Related]
38. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R. J Psychopharmacol; 2008 Jul 15; 22(5):498-510. PubMed ID: 18208910 [Abstract] [Full Text] [Related]
39. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems. Parrott AC, Milani RM, Parmar R, Turner JD. Psychopharmacology (Berl); 2001 Dec 15; 159(1):77-82. PubMed ID: 11797073 [Abstract] [Full Text] [Related]
40. MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature. O'Shea E, Orio L, Escobedo I, Sanchez V, Camarero J, Green AR, Colado MI. Br J Pharmacol; 2006 Jul 15; 148(6):778-85. PubMed ID: 16770327 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]